Integrichain Blog

Blog

Pharmaceutical team discussing the future of the pharmaceutical industry

Specialty Pharmacy William Roth
May 15, 2023

Thoughts Following Asembia 2023 Part 1: Exploring the New Pharmacy Landscape

2 Minute Read

Channel expert Bill Roth explores how specialty pharmacy has evolved and their take on the current landscape and insights for pharmaceutical organizations.

340b contract pharmacy

Contracts & Pricing Rupal Patel Michael Gorokhovsky Carter Hall
April 24, 2023

340B Contract Pharmacy Restrictions, M&A Funding in Biotech & FDA Accelerated...

6 Minute Read

Updates on 340B Contract Pharmacy Restriction Updates, M&A and Venture Capital Funding in Biotech, and Stricter Accelerated Approval Criteria Proposed for FDA.

pharma digital transformation

Gross-to-Net Manli Gomari
April 17, 2023

Why Modernize Your Gross-to-Net? 5 Benefits of Pharma Digital Transformation

2 Minute Read

In the current pharma landscape, more than 80% of manufacturers still rely on manual processes to accrue, forecast, and report their gross-to-net (GTN) deductions. This is primarily because of...

Government Pricing John Whitridge
April 7, 2023

State Pricing Transparency Reporting – Part 2

3 Minute Read

Explore the best practice recommendations regarding compliance for SPTR.

Hospital hallway with medical icons overlaid, emphasizing the importance of Inflation Reduction Act guidance for pharmaceutical manufacturers

Contracts & Pricing Brian Bumpus Carter Hall
March 29, 2023

Updates on MDRP NOTICE Release No. 117, Inflation Reduction Act Guidance...

5 Minute Read

Updates on MDRP NOTICE Release No. 117, Inflation Reduction Act, and Operationalizing Medicare Inflationary Rebates.

Pharma market access strategy for pre and post launch

Launch Readiness Rupal Patel
March 21, 2023

Perspectives on Pharma Market Access Launch Challenges & Strategy Part 2

9 Minute Read

We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.

Three Pharma regulatory consultants working at a table and planning their pharma gross-to-net strategy

Gross-to-Net Jen Sharpe Andrea Zagarola
March 6, 2023

5 Pharma Gross-to-Net Questions You Should Be Asking

4 Minute Read

Whether manufacturers are entering new therapeutic categories, exploring new indications for a current product, or looking to acquire a new product through acquisition, managing Gross-To-Net can be complex.

orphan drug

Contracts & Pricing Nick Iaconi Jui Andhare
February 27, 2023

FDA Set to Apply Orphan-Drug Exclusivity, 2022 Employer Health Benefits Survey...

5 Minute Read

Updates on two significant regulatory topics, including the FDA decision on orphan-drug exclusivity regulations and highlights from the Kaiser Family Foundation 2022 Employer Benefits Survey.

Pharma market access strategy for pre and post launch

Launch Readiness Rupal Patel
February 7, 2023

Perspectives on Pharma Market Access Launch Challenges & Strategy Part 1

5 Minute Read

We asked three market access leaders with significant launch experience across varying therapeutic categories about their launch journey–from pre-launch strategy and planning to post-launch optimization.

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article